Invacare chapter 11 filing
We are advising Highbridge Capital in connection with the restructuring
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Amgen $28.5 billion Horizon Therapeutics acquisition financing
We advised the lender parties on the financing
Walgreens $2.25 billion Summit Health-CityMD acquisition financing
We are advising the lender in connection with the facilities
Blackstone and CPPIB $1.96 billion Advarra acquisition financing
We advised the lead arrangers and initial term lenders on the financing
ADC Therapeutics $175 million term loan facility and other financings
We advised the company on the new facility, a $115 million exchange and a $6.25 million share sale
Envision Healthcare and AMSURG $600 million new credit facilities
We advised the agent on an amendment including a $300 million “first out” tranche and on a new $300 million revolver
Acutus Medical sale of its left-heart access portfolio products and refinancing
We advised Acutus Medical on the transactions
Astorg acquisition of OPEN Health
We are advising Astorg on the transaction
Bausch + Lomb $630 million IPO
We are advising Bausch Health on the separation of its eye health business into a new public company, Bausch + Lomb
Acutus Medical sale of its left-heart access portfolio products
We are advising Acutus Medical on the transaction